Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Vyrologix (leronlimab)
i
Other names:
PRO 140, PRO-140, PA-14, PA14
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
CytoDyn, Lantheus, Vyera Pharma, amfAR
Drug class:
CCR5 receptor antagonist, Viral entry inhibitor
Related drugs:
‹
5P12-RANTES (0)
BMS-813160 (0)
5P12-RANTES (0)
BMS-813160 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCR5 positive
Triple Negative Breast Cancer
CCR5 positive
Triple Negative Breast Cancer
leronlimab
Sensitive: C3 – Early Trials
leronlimab
Sensitive
:
C3
leronlimab
Sensitive: C3 – Early Trials
leronlimab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login